Suppr超能文献

一项前瞻性随机研究比较了硬脑膜下和骨膜下引流治疗慢性硬脑膜下血肿的效果和结果。

A prospective randomised study to compare the utility and outcomes of subdural and subperiosteal drains for the treatment of chronic subdural haematoma.

机构信息

Department of Neurosurgery, Cork University Hospital, Cork, Republic of Ireland.

出版信息

Acta Neurochir (Wien). 2012 Nov;154(11):2083-8; discussion 2088-9. doi: 10.1007/s00701-012-1483-1. Epub 2012 Aug 30.

Abstract

BACKGROUND

The usage of a drain following evacuation of a chronic subdural haematoma (CSDH) is known to reduce recurrence. In this study we aim to compare the clinical outcomes and recurrence rate of utilising two different types of drains (subperiosteal and subdural drain) following drainage of a CSDH.

METHODS

Prospective randomised single-centre study analysing 50 patients who underwent CSDH treatment. Two types of drains, subperiosteal (SPD) and subdural (SDD), were utilised on consecutive alternate patients following burr-hole craniostomy, with a total of 25 patients in each group. The drains were left in for 48-h duration and then removed. The modified Rankin Scale (mRS) was used for outcome measurement at 3 and 6 months.

RESULTS

Data analysis was performed by unpaired t test with Welch's correction. It was observed that none of the patients in either group had haematoma recurrence during a 6-month follow-up, and a significant difference in outcome was noted at 6 months (p = 0.0118) more than at 3 months (p = 0.0493) according to the statistical analysis. Postoperative seizure and inadvertent placement of the subdural drain into the brain parenchyma were the two complications noted in this study. Anticoagulant use prior to the surgery did not affect the outcome in either group.

CONCLUSIONS

We conclude there was no recurrence of CSDH utilising the SDD and SPD following burr-hole craniostomy. The mRS measurement at the 6-month follow-up was found to be statistically significant, with better outcomes with utilisation of the SPD. The SPD may thus prove to be more beneficial than the SDD in the treatment of CSDH. A multi-centre study with a larger group of patients is recommended to reinforce the results from our study.

摘要

背景

慢性硬脑膜下血肿(CSDH)引流后使用引流管已被证实可降低复发率。本研究旨在比较颅骨钻孔术后使用两种不同类型引流管(骨膜下和硬脑膜下引流管)治疗 CSDH 的临床效果和复发率。

方法

前瞻性随机单中心研究分析了 50 例接受 CSDH 治疗的患者。颅骨钻孔术后,连续交替使用两种引流管(骨膜下引流管[SPD]和硬脑膜下引流管[SDD]),每组 25 例。引流管留置 48 小时后拔除。采用改良 Rankin 量表(mRS)在 3 个月和 6 个月时评估预后。

结果

采用配对 t 检验(Welch 校正)进行数据分析。结果显示,两组患者在 6 个月的随访中均无血肿复发,且在 6 个月时的预后(p=0.0118)明显优于 3 个月时(p=0.0493)。根据统计学分析。术后癫痫发作和意外将硬脑膜下引流管置入脑实质是本研究中观察到的两种并发症。术前使用抗凝剂在两组中均未影响预后。

结论

我们得出结论,颅骨钻孔术后使用 SDD 和 SPD 均未发生 CSDH 复发。6 个月随访时 mRS 测量结果具有统计学意义,使用 SPD 的预后更好。因此,与 SDD 相比,SPD 在 CSDH 的治疗中可能更有益。建议进行一项多中心、更大样本量的研究,以验证我们的研究结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验